Amal Hofni
Qina, KN, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Thiadiazolo-Triazolo-Pyrimidine Hybrids as Dual Aurora A/ERK Inhibitors: Design, Synthesis, and Apoptotic Activity.
Journal: Drug development research
Published: March 26, 2026
Celastrol Mitigates Colistin-Induced Renal Toxicity in Rats via Modulating Nrf-2/HO-1 and NF-κB Signaling Pathways.
Journal: Journal of biochemical and molecular toxicology
Published: July 21, 2025
Berberine Alleviates Uterine Inflammation in Rats via Modulating the TLR-2/p-PI3K/p-AKT Axis.
Journal: International immunopharmacology
Published: June 04, 2024
Celastrol protects against cisplatin-induced ovarian toxicity via modulation of PPAR-γ and AMPK.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 06, 2024
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: May 11, 2023
Ginger Extract-Loaded Transethosomes for Effective Transdermal Permeation and Anti-Inflammation in Rat Model.
Journal: International journal of nanomedicine
Published: December 07, 2022
Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 01, 2022
Renoprotective Effect of Thymoquinone against Streptozotocin-Induced Diabetic Nephropathy: Role of NOX2 and Nrf2 Signals.
Journal: Current molecular pharmacology
Published: August 07, 2022
Selective Targeting of the Novel CK-10 Nanoparticles to the MDA-MB-231 Breast Cancer Cells.
Journal: Journal of pharmaceutical sciences
Published: June 13, 2021
Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 25, 2016
Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Journal: European journal of pharmacology
Published: July 05, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026